Boston Scientific shares fell 9.03% to $62.92 on Monday, with trading volume at 39.9, after investors reacted to new clinical-trial information on its Watchman heart implant. The move indicates market concern about the device's clinical data and could pressure the company's near-term outlook and valuation.
Boston Scientific shares fell 9.03% to $62.92 on Monday, with trading volume at 39.9, after investors reacted to new clinical-trial information on its Watchman heart implant. The move indicates market concern about the device's clinical data and could pressure the company's near-term outlook and valuation.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.65
Ticker Sentiment
